👤 Hyeyoon Kim

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
849
Articles
999
Name variants
Also published as: Mi Ok Kim, S Y Kim, Chul-Hong Kim, Do Hyung Kim, Sydney Y Kim, Sung Young Kim, Chongtae Kim, Myung-Sunny Kim, Hyeong-Rok Kim, Miri Kim, Dong Il Kim, Hyeon-Ah Kim, Esther Kim, Ok-Hwa Kim, Juyong B Kim, Joong-Seok Kim, Jong Woo Kim, Saerom Kim, Wondong Kim, Seong-Hyun Kim, Misung Kim, Dong-Ik Kim, Minsuk Kim, Ohn Soon Kim, Sung Han Kim, Sung Tae Kim, Richard Kim, Albert H Kim, Ju Deok Kim, Chong Ae Kim, Hyun-Ji Kim, Yong Kyung Kim, Jisun Kim, Haein Kim, Jeonghan Kim, Hee Jin Kim, Minjae Kim, Hyun Kim, Kyoung Oh Kim, Jiyea Kim, Jun Hoe Kim, Joon Kim, Sunghwan Kim, Bo-Rahm Kim, Namkyoung Kim, Hee Jeong Kim, Kangjoon Kim, Younghoon Kim, Jae Geun Kim, Min Kyeong Kim, Hyeong-Taek Kim, Kevin K Kim, Soeun Kim, Sungup Kim, Jeong Su Kim, Gwang Sik Kim, Anthony S Kim, Ok Jin Kim, Jeongseop Kim, Bo-Eun Kim, Suk-Kyung Kim, Sang Soo Kim, Hae Won Kim, Taeil Kim, Joonyoung R Kim, Kyung-Hee Kim, Hyojin Kim, Yangseok Kim, Jong Ho Kim, Chunki Kim, Seokjoong Kim, Mi Ra Kim, Young-Dae Kim, Young Mi Kim, Na-Kuang Kim, Yoon Sook Kim, Byoung Jae Kim, Daham Kim, Mijung Kim, Yu Kyeong Kim, Yong-Lim Kim, Jin-Chul Kim, Chan Wook Kim, Hyeong-Jin Kim, Sang Hyuk Kim, Gibae Kim, Sang Ryong Kim, Jieun Kim, Jongchan Kim, Joseph C Kim, Jun Pyo Kim, Brandon J Kim, Jun-Sik Kim, Ji Eun Kim, Jung-In Kim, Chan-Wha Kim, B-Y Kim, B T Kim, Dahee Kim, Taek-Yeong Kim, Hyunjoon Kim, Young-Saeng Kim, Hyeon Jeong Kim, Hyemin Kim, Shin Kim, Y S Kim, Dan Say Kim, Ji-Dam Kim, Paul T Kim, Kyoung Hoon Kim, Ye-Ri Kim, Hee-Jin Kim, Jason Kim, Youngsin Kim, Hyuk Soon Kim, Seung-Ki Kim, Moon Suk Kim, Young Ju Kim, Yunwoo Kim, J Y Kim, Lia Kim, Soo-Hyun Kim, Byung Jin Kim, You-Sun Kim, Youngsoo Kim, Yunkyung Kim, Meelim Kim, Kye-Seong Kim, Minseon Kim, Hye-Jin Kim, Il-Man Kim, Dong Ha Kim, Soo Yoon Kim, Stuart K Kim, Soo Hyun Kim, Il-Chan Kim, Mi-Na Kim, Yeong-Sang Kim, Eunmi Kim, Taewan Kim, Yun Seok Kim, Kyung Hee Kim, M Kim, Hyun Eun Kim, Eunkyeong Kim, Soee Kim, Young-Im Kim, So-Hee Kim, Hyeong Hoe Kim, Hee Young Kim, Eungseok Kim, Sungyun Kim, Tae-You Kim, Jong-Yeon Kim, Tae Hoon Kim, Sungrae Kim, Eun-Jin Kim, Heejin Kim, Tae Jin Kim, Ju Young Kim, Un-Kyung Kim, Jin Woo Kim, Gu-Hwan Kim, Young-Mi Kim, Dae-Kyum Kim, Tae-Min Kim, Seon-Kyu Kim, Hana Kim, Hye Ran Kim, Yuli Kim, Jung Ho Kim, Edwin H Kim, Grace Kim, Jongho Kim, Soung Jung Kim, Jinsup Kim, Dong-Kyu Kim, Su-Hyeong Kim, Kee-Tae Kim, Nam-Ho Kim, Jin Gyeom Kim, Mi Young Kim, Hyun-Sic Kim, Kyung-Sup Kim, Hyeonwoo Kim, Dong Gwang Kim, Jong-Youn Kim, Doo Yeon Kim, Jong-Il Kim, Soo Whan Kim, Kwang-Eun Kim, Jong-Won Kim, Eung-Gook Kim, Jaehoon Kim, Hyoung Kyu Kim, Hark Kyun Kim, Jonggeol J Kim, Sang Eun Kim, Jeong Kyu Kim, Eun Ji Kim, Youngmi Kim, William Kim, Jiho Kim, Dae In Kim, Dennis Y Kim, Sunghun Kim, Nari Kim, Doyeon Kim, Sang-Min Kim, Myeong-Kyu Kim, Youngsook Kim, Angela H Kim, Hye-Jung Kim, Hyung-Suk Kim, Hang-Rai Kim, Hyoun-Ah Kim, Sung-Wan Kim, Myung-Sun Kim, Mi Kyung Kim, Eun Young Kim, Jinhee Kim, Hyung-Gu Kim, Woo Sik Kim, In Suk Kim, Sung Eun Kim, Yekaterina Kim, Juyoung Kim, Hong-Hee Kim, Hye-Sung Kim, Ji Hyun Kim, Kyung Mee Kim, Sunghak Kim, Dong-Hoon Kim, Yong-Wan Kim, Seul Young Kim, Myoung Ok Kim, Jong-Seok Kim, H Kim, Minsik Kim, Sang-Young Kim, June-Bum Kim, Dong Hyun Kim, Jihoon Kim, Jaegil Kim, Tae Wan Kim, Seonggon Kim, Seongho Kim, Dong Wook Kim, Jun-Hyung Kim, Don-Kyu Kim, Kyung An Kim, Jun Suk Kim, Jung-Lye Kim, Dongkyun Kim, Sung Kyun Kim, Yerin Kim, Seung Woo Kim, Jun W Kim, Eunae Kim, Won Tae Kim, Kyung-Sub Kim, Kang Ho Kim, Chul Hwan Kim, Yong Sig Kim, Hong-Kyu Kim, Go Woon Kim, Peter K Kim, Taeeun Kim, Eunhyun Kim, Min-Sik Kim, Hyejin Kim, Chang-Yub Kim, Kyunggon Kim, Sinai Kim, Jiyeon Kim, Chong Kook Kim, Minkyung Kim, Cecilia E Kim, Jae Seon Kim, Yeon-Jeong Kim, Ha-Neui Kim, Kwan Hyun Kim, Jongwan Kim, Young Hun Kim, Nam Hee Kim, Jong Yeol Kim, Ji-Hoon Kim, Ki Tae Kim, Young-Bum Kim, Hyojung Kim, Woonhee Kim, Minjeong Kim, Sae Hun Kim, Sohee Kim, Jong-Joo Kim, Sangsoo Kim, Yong-Woon Kim, Geun-Young Kim, Jae-Jun Kim, K-K Kim, Jung-Taek Kim, Jeeyoung Kim, Min-Sun Kim, Kwang Pyo Kim, Ngoc-Thanh Kim, Chan-Duck Kim, Hyeon Ho Kim, Soo-Youl Kim, Young Tae Kim, Shi-Mun Kim, Kwang-Pyo Kim, Hee Jong Kim, Minah Kim, Taehyoun Kim, Yonghwan Kim, Won Dong Kim, Su-Jeong Kim, Eunha Kim, Min-Hyun Kim, Kyeongjin Kim, Min Kim, Sung Won Kim, Se-Wha Kim, Myeoung Su Kim, Eonmi Kim, In-Hoo Kim, Nan Young Kim, Myeong Ok Kim, Wootae Kim, In Kyoung Kim, Leen Kim, Doo Yeong Kim, Do-Hyung Kim, Dong-Hyeok Kim, Joonseok Kim, So Yeon Kim, Kwangho Kim, Seok Won Kim, Bo Ri Kim, TaeHyung Kim, Woo Jin Kim, Misun Kim, Serim Kim, Junesun Kim, Young Ree Kim, Choel Kim, Jae Hun Kim, Jin-Soo Kim, Jimi Kim, You-Jin Kim, Goun Kim, Goo-Young Kim, Jong Han Kim, Bongjun Kim, Sun-Joong Kim, Young Ho Kim, Kyung Sup Kim, Young Jin Kim, Scott Y H Kim, Chang Seong Kim, Ryung S Kim, Kellan Kim, Han Gyung Kim, Jae Hoon Kim, Jung-Ha Kim, Jaeyeon Kim, Hyung-Mi Kim, Hye-Young H Kim, Ho Shik Kim, Hwijin Kim, Kyungtae Kim, Ki Kwon Kim, Yongae Kim, Jaemi Kim, Hyun-ju Kim, Tai Kyoung Kim, Se Hyun Kim, Hyeseon Kim, Jin Cheon Kim, Hyung-Ryong Kim, Carla F Kim, Hyunki Kim, Yong-Sik Kim, Joonki Kim, Hyung-Sik Kim, Ah-Ram Kim, Deok Ryong Kim, Hyunyoung Kim, Jung Ki Kim, Yongkang Kim, Brian S Kim, Minchul Kim, Kahye Kim, Jae-Ryong Kim, Heegoo Kim, In Joo Kim, Sung-Jo Kim, Sang Chan Kim, Kyuho Kim, Sunkyu Kim, Beom-Jun Kim, Wanil Kim, Hei Sung Kim, Woojin Scott Kim, Won Jeoung Kim, Jungwoo Kim, Yejin Kim, Kyu-Kwang Kim, Yong-Soo Kim, Yong-Ou Kim, M J Kim, Yoonjung Kim, Chul Hoon Kim, Hyun-Jung Kim, Jae Hyoung Kim, Hyun Joon Kim, Hyun-Jin Kim, Ok-Kyung Kim, Kyungsook Kim, Kyungwon Kim, Jin Kim, Suji Kim, Ok-Hyeon Kim, Jung-Woong Kim, Seoyeon Kim, Kyeong-Min Kim, Sang-Hoon Kim, Hyun Gi Kim, Jooho Kim, Myung-Jin Kim, Eun-Jung Kim, Sangchul Kim, Joori Kim, Min Jung Kim, Jeeho Kim, Jihye Kim, Mi-Young Kim, Choon Ok Kim, Na Yeon Kim, Seong-Ik Kim, Jisu Kim, Dong-Hyun Kim, Myungsuk Kim, Eui Hyun Kim, Won-Tae Kim, Sung Soo Kim, Eun Kim, Hyung Min Kim, Jihyun Kim, Kwang Dong Kim, Suhyun Kim, Elizabeth H Kim, Sang-Gun Kim, Han-Kyul Kim, Yong Deuk Kim, Jong-Seo Kim, Young-Ho Kim, Yoo Ri Kim, Eiru Kim, Ji Yeon Kim, Ki Hyun Kim, Tae Hun Kim, Ae-Jung Kim, Eosu Kim, Cheorl-Ho Kim, TaeYeong Kim, Yeon-Hee Kim, Jae Suk Kim, Richard B Kim, Young-Jin Kim, Deokhoon Kim, Eung Yeop Kim, K-S Kim, Daeseung Kim, Ji Hun Kim, Mi-Sung Kim, Young Woo Kim, Taehyeung Kim, Meesun Kim, Sook Young Kim, Jaewon Kim, In Su Kim, Heebal Kim, Seungsoo Kim, Bong-Jo Kim, Seon Hwa Kim, Luke Y Kim, Jae-Ick Kim, Hwajung Kim, Jisook Kim, Jeffrey J Kim, Kyung Do Kim, Jungeun Kim, Youbin Kim, Jeong-Min Kim, Seokhwi Kim, D-W Kim, Su-Yeon Kim, Jung Hee Kim, Wook Kim, Jun-Mo Kim, Seon Hee Kim, Hong-Gi Kim, Hyun-Young Kim, Young Hwa Kim, Hyung Bum Kim, Dae-Soo Kim, Gitae Kim, Hyun-Yi Kim, Sejoong Kim, Hyungsoo Kim, Hyunmi Kim, June Soo Kim, Gyudong Kim, Rokki Kim, Yong Sook Kim, Young-Il Kim, Jinsu Kim, Woo-Yang Kim, Eunjoon Kim, Woo Kim, Jang-Hee Kim, Won Seok Kim, Seung Tea Kim, Tae Il Kim, Sung-Hou Kim, H S Kim, Suhyung Kim, Jong-Ho Kim, Jong Heon Kim, So Young Kim, Yeonsoo Kim, Jiha Kim, Young-Youn Kim, Hye Yun Kim, Arie Kim, Sun-Hee Kim, Min Wook Kim, Hyung-Jun Kim, Jae Hyun Kim, Sewoon Kim, Jin Seok Kim, Eunju Kim, Yun Hye Kim, Sun-Hong Kim, Soyeong Kim, Sowon Kim, Young Sik Kim, Mi-Hyun Kim, Byung-Gyu Kim, JongKyong Kim, Jin Young Kim, So Ree Kim, Aram Kim, Youn-Jung Kim, Joung Sug Kim, Hail Kim, Eui Jin Kim, Cheol-Su Kim, Ngoc Thanh Kim, Seong-Seop Kim, Ji-Man Kim, Ju-Kon Kim, Soo Wan Kim, Woong-Ki Kim, Ju-Wan Kim, Sunggun Kim, Sun Woong Kim, Jin Kyong Kim, Hoguen Kim, Hyungkuen Kim, Ji Hye Kim, Myoung Hee Kim, Min Ju Kim, Deok-Ho Kim, Woo-Shik Kim, Mina K Kim, Kiyoung Kim, Paul H Kim, Eun-Kyung Kim, Da-Sol Kim, Yeaseul Kim, In Ja Kim, Beomsu Kim, Byungwook Kim, Sun Yeou Kim, Jongmyung Kim, Helen Kim, Sungyeon Kim, Dae-Eun Kim, Jayoun Kim, Jung Dae Kim, Joseph Han Sol Kim, E-S Kim, Boo-Young Kim, Sung-Mi Kim, Dongwoo Kim, Seul-Ki Kim, Hye Jin Kim, Soo Young Kim, Sukjun Kim, Dong Joon Kim, Hyo Jung Kim, Yeseul Kim, Yong Sik Kim, Nam-Eun Kim, Sang-Tae Kim, Hong Sug Kim, Youngjoo Kim, Sun-Gyun Kim, Min-Gon Kim, Young-Woo Kim, Myungshin Kim, Tae Hoen Kim, Soon Hee Kim, Won Kim, Chanhee Kim, Jung Oh Kim, Hyun-Kyong Kim, Jeffrey Kim, Yeonhwa Kim, Yeon Ju Kim, Duck-Hee Kim, Seohyeon Kim, Soon Sun Kim, Jae Bum Kim, Yeul Hong Kim, Juhyun Kim, Chang-Gu Kim, Gwangil Kim, Alison J Kim, Hwa-Jung Kim, Youngeun Kim, Cheol-Hee Kim, NamHee Kim, Byung-Chul Kim, Cecilia Kim, S Kim, Tae-Gyu Kim, Kwan-Suk Kim, Jee Ah Kim, Kyoungtae Kim, Seong Jun Kim, Mi Jeong Kim, Myoung Sook Kim, Chu-Young Kim, Minsu Kim, Seong-Tae Kim, Donghyeon Kim, Sunoh Kim, Yu-Jin Kim, Yul-Ho Kim, Eric Kim, Jae-Young Kim, Jin Hee Kim, Tae Min Kim, Yeji Kim, Yo-Han Kim, Kyong-Tai Kim, Dae-Kyeong Kim, June Hee Kim, Tae Hyun Kim, Leo A Kim, Young S Kim, Min Bum Kim, Min Seo Kim, Seong-Jin Kim, Young-Chul Kim, Jinkyeong Kim, SooHyeon Kim, Kwangwoo Kim, Dong-Hee Kim, Sang Wun Kim, Won J Kim, Seung Won Kim, Ji-Yul Kim, Moo-Yeon Kim, Do Yeon Kim, Jun Seok Kim, Su-Jin Kim, Jewoo Kim, A Ram Kim, Hyung Hoi Kim, Song-Rae Kim, Hye-Ran Kim, Yoongeum Kim, Jeong-Han Kim, Jinsoo Kim, Steve Kim, Taeyoung Kim, Hwi Seung Kim, Hye Ree Kim, Hyeong-Geug Kim, Yu Mi Kim, J H Kim, Suk Jae Kim, Sung-Hee Kim, Na-Young Kim, Minji Kim, Jongkyu Kim, Jae-Yoon Kim, Hyunjin Kim, Helen B Kim, Dong-Yi Kim, Ji-Yun Kim, Sung Woo Kim, Ha-Jung Kim, Yongmin Kim, Han Young Kim, Hyun-Soo Kim, Hyunju Kim, Jin Man Kim, Young Nam Kim, Hye Young Kim, Sung Yeol Kim, Jong-Oh Kim, Y-D Kim, Jong-Hyun Kim, Jenny H Kim, Youngchang Kim, Okhwa Kim, Y A Kim, Won Kyung Kim, Dongjoon Kim, Myung Jin Kim, Hannah Kim, Ick Young Kim, Hyunsoo Kim, Sungjoo Kim, Seonhee Kim, Y-M Kim, Sun Hee Kim, Jung Sun Kim, Ji Young Kim, Sung-Eun Kim, Wun-Jae Kim, Hee Nam Kim, Vladimir Kim, Donghee Kim, Sang Jin Kim, Won Ho Kim, Byeong-Won Kim, Hyung-Goo Kim, J Julie Kim, Jiwon Kim, Eun-Joo Kim, Hyun Soo Kim, Tae-Hyoung Kim, Anna Kim, Gahyun Kim, Jong Hwan Kim, Borahm Kim, Caroline Kim, Andrea J Kim, Yong-Hoon Kim, Jisup Kim, Yong Kyun Kim, Young-Eun Kim, Angela Kim, Tae-Eun Kim, Ji Won Kim, Sang Geon Kim, Young-Cho Kim, Bo Young Kim, Minsoon Kim, Paul Kim, Jeongseon Kim, Tae-Mi Kim, Oc-Hee Kim, Da-Hyun Kim, Jong Geun Kim, Woo Kyung Kim, Jae-Yong Kim, Jaeuk U Kim, Kye Hyun Kim, Dae-Jin Kim, Jun Chul Kim, Dae Keun Kim, You Sun Kim, Heung-Joong Kim, Angela S Kim, Ji-Young Kim, So-Woon Kim, Dayoung Kim, Sangwoo Kim, Eric Eunshik Kim, Yeeun Kim, Jeewoo Kim, Sungmin Kim, Hyun Sil Kim, Young Hee Kim, Kyunga Kim, Donghyun Kim, Sung-Kyu Kim, Hanah Kim, Do-Kyun Kim, Jonggeol Jeffrey Kim, Min Soo Kim, Ju Han Kim, Hyung Yoon Kim, Youngchul Kim, Minhee Kim, Byung-Taek Kim, Sung-Bae Kim, Suk-Jeong Kim, Min-A Kim, Jae T Kim, Dong-Seok Kim, Min-Seon Kim, Hyoun Ju Kim, JungMin Kim, Kwonseop Kim, Kyong Min Kim, Jae-Jung Kim, Howard H Kim, Min-Seo Kim, Minjoo Kim, Sujung Kim, Woo-Kyun Kim, Yongjae Kim, Jong-Kyu Kim, Dong-il Kim, Jeri Kim, Seol-A Kim, Soriul Kim, Kil-Nam Kim, Soo-Rim Kim, Yun-Jin Kim, Yeonjung Kim, Su Jin Kim, Kyung Woo Kim, Yeon-Jung Kim, Jeong Hee Kim, Youn Shic Kim, Dong-Eun Kim, So-Yeon Kim, C H Kim, Sung-Hoon Kim, Namphil Kim, Kyung-Chang Kim, Chan-Hee Kim, Sun Hye Kim, Seulhee Kim, Joonyoung Kim, Gunhee Kim, Joungmok Kim, Seung-Whan Kim, Sang-Woo Kim, Seongmi Kim, Daegyeom Kim, Da Sol Kim, Ellen Kim, Young Rae Kim, Hee-Sun Kim, Seung Jun Kim, Kyungjin Kim, Youn-Kyung Kim, Sunghoon Kim, Jung-Hyun Kim, Young Eun Kim, Ho-Sook Kim, Hyun Ju Kim, Gyeonghun Kim, Baek Kim, Soon-Hee Kim, David E Kim, Joong Sun Kim, Hoon Seok Kim, Yunjung Kim, Keun You Kim, Min Cheol Kim, Gye Lim Kim, Dakyung Kim, Jong Won Kim, Hoon Kim, Seung-Jin Kim, Myeong Ji Kim, NamDoo Kim, Jinho Kim, Hyo Jong Kim, Young-Woong Kim, Un Gi Kim, Tae-Hyun Kim, Kee-Pyo Kim, Oh Yoen Kim, Juyeong Kim, Jun Hee Kim, Chae-Hyun Kim, Leo Kim, Eun Ho Kim, Haeryoung Kim, Seong Kim, Jessica Kim, Jin Won Kim, Hyun Sook Kim, Kyeongmi Kim, Rosalind Kim, Sujin Kim, E Kim, Nam-Hyung Kim, Sin Gon Kim, Seohyun Kim, Boram Kim, Kyeong Jin Kim, Gi Beom Kim, Jason K Kim, Hyung-Seok Kim, Dae Hyun Kim, Jina Kim, Ji-Won Kim, Eui-Soon Kim, Minkyeong Kim, M V Kim, Yumi Kim, Sunyoung Kim, Maya Kim, Mijeong Kim, Hyunbae Kim, Esl Kim, Su Kang Kim, Ju-Ryoung Kim, Bomi Kim, Kyung Han Kim, Seoyoung Kim, Ji-Eun Kim, Yoojin Kim, Minju Kim, Tae-Woon Kim, Jae Gon Kim, Hyeong Su Kim, Choon-Song Kim, Kye Hun Kim, Hyesung Kim, Yeon-Ki Kim, Jaeyoon Kim, Hyeung-Rak Kim, Kook Hwan Kim, Sung Hyun Kim, Sol Kim, Hyunwoo Kim, Min Joo Kim, Dong-Wook Kim, Young Sam Kim, Hye-Yeon Kim, Yun Joong Kim, Ki Woong Kim, Jungsu Kim, Misu Kim, Seung Chul Kim, Mi-Yeon Kim, Hyo-Soo Kim, Won Kon Kim, Sangmi Kim, Jong Deog Kim, Yun Gi Kim, Seon-Young Kim, Il-Sup Kim, Byung Guk Kim, Susy Kim, Youngwoo Kim, Min-Young Kim, Jae-Min Kim, Yong Sung Kim, Young-Won Kim, Jung H Kim, Eun Hee Kim, Yong Kwan Kim, Haelee Kim, Daesik Kim, Woo-Jin Kim, Gukhan Kim, Hyungjun Kim, Young-Hoon Kim, Jong-Ki Kim, Byron Kim, Taek-Kyun Kim, Bo-Ra Kim, Dokyoon Kim, Min Chul Kim, Miso Kim, Seong-Min Kim, Jang Heub Kim, Hyeyoung Kim, Hyunwook Kim, Hee Su Kim, Young-Joo Kim, Reuben H Kim, Hong-Kook Kim, Soo Jung Kim, Sungryong Kim, Taejung Kim, Jung Soo Kim, Kyoung Hwan Kim, Sung Mok Kim, Daeeun Kim, Hyelim Kim, Beomsoo Kim, Ji-Woon Kim
articles
Ji-Yoon Lee, Miso Nam, Hye Young Son +21 more · 2020 · Proceedings of the National Academy of Sciences of the United States of America · National Academy of Sciences · added 2026-04-24
Ferroptosis is an iron-dependent regulated necrosis mediated by lipid peroxidation. Cancer cells survive under metabolic stress conditions by altering lipid metabolism, which may alter their sensitivi Show more
Ferroptosis is an iron-dependent regulated necrosis mediated by lipid peroxidation. Cancer cells survive under metabolic stress conditions by altering lipid metabolism, which may alter their sensitivity to ferroptosis. However, the association between lipid metabolism and ferroptosis is not completely understood. In this study, we found that the expression of elongation of very long-chain fatty acid protein 5 (ELOVL5) and fatty acid desaturase 1 (FADS1) is up-regulated in mesenchymal-type gastric cancer cells (GCs), leading to ferroptosis sensitization. In contrast, these enzymes are silenced by DNA methylation in intestinal-type GCs, rendering cells resistant to ferroptosis. Lipid profiling and isotope tracing analyses revealed that intestinal-type GCs are unable to generate arachidonic acid (AA) and adrenic acid (AdA) from linoleic acid. AA supplementation of intestinal-type GCs restores their sensitivity to ferroptosis. Based on these data, the polyunsaturated fatty acid (PUFA) biosynthesis pathway plays an essential role in ferroptosis; thus, this pathway potentially represents a marker for predicting the efficacy of ferroptosis-mediated cancer therapy. Show less
no PDF DOI: 10.1073/pnas.2006828117
FADS1
Yoshio Hirabayashi, Yeon-Jeong Kim · 2020 · Journal of biochemistry · Oxford University Press · added 2026-04-24
In the past decade, physiological roles and molecular functions of GPRC5 family receptors, originally identified as retinoic acid-induced gene products, have been uncovered, even though their intrinsi Show more
In the past decade, physiological roles and molecular functions of GPRC5 family receptors, originally identified as retinoic acid-induced gene products, have been uncovered, even though their intrinsic agonists are still a mystery. They are differentially distributed in certain tissues and cells in the body suggesting that cell-type-specific regulations and functions are significant. Molecular biological approaches and knockout mouse studies reveal that GPRC5 family proteins have pivotal roles in cancer progression and control of metabolic homeostasis pathways. Remarkably, GPRC5B-mediated tyrosine-phosphorylation signalling cascades play a critical role in development of obesity and insulin resistance through dynamic sphingolipid metabolism. Show less
no PDF DOI: 10.1093/jb/mvaa030
GPRC5B
Sung Hye Kong, Ji Won Yoon, Jung Hee Kim +6 more · 2020 · Endocrinology and metabolism (Seoul, Korea) · added 2026-04-24
As the genetic variants of trabecular bone microarchitecture are not well-understood, we performed a genome-wide association study to identify genetic determinants of bone microarchitecture analyzed b Show more
As the genetic variants of trabecular bone microarchitecture are not well-understood, we performed a genome-wide association study to identify genetic determinants of bone microarchitecture analyzed by trabecular bone score (TBS). TBS-associated genes were discovered in the Ansung cohort (discovery cohort), a community-based rural cohort in Korea, and then validated in the Gene-Environment Interaction and Phenotype (GENIE) cohort (validation cohort), consisting of subjects who underwent health check-up programs. In the discovery cohort, 2,451 participants were investigated for 1.42 million genotyped and imputed markers. In the validation cohort, identified as significant variants were evaluated in 2,733 participants. An intronic variant in iroquois homeobox 3 (IRX3), rs1815994, was significantly associated with TBS in men (P=3.74E-05 in the discovery cohort, P=0.027 in the validation cohort). Another intronic variant in mitogen-activated protein kinase kinase 5 (MAP2K5), rs11630730, was significantly associated with TBS in women (P=3.05E-09 in the discovery cohort, P=0.041 in the validation cohort). Men with the rs1815994 variant and women with the rs11630730 variant had lower TBS and lumbar spine bone mineral density. The detrimental effects of the rs1815994 variant in men and rs11630730 variant in women were also identified in association analysis (β=-0.0281, β=-0.0465, respectively). In this study, the rs1815994 near IRX3 in men and rs11630730 near MAP2K5 in women were associated with deterioration of the bone microarchitecture. It is the first study to determine the association of genetic variants with TBS. Further studies are needed to confirm our findings and identify additional variants contributing to the trabecular bone microarchitecture. Show less
📄 PDF DOI: 10.3803/EnM.2020.735
MAP2K5
Sandra Cristea, Garry L Coles, Daniel Hornburg +13 more · 2020 · Cancer research · added 2026-04-24
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with dismal survival rates. While kinases often play key roles driving tumorigenesis, there are strikingly few kinases known to promo Show more
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with dismal survival rates. While kinases often play key roles driving tumorigenesis, there are strikingly few kinases known to promote the development of SCLC. Here, we investigated the contribution of the MAPK module MEK5-ERK5 to SCLC growth. MEK5 and ERK5 were required for optimal survival and expansion of SCLC cell lines Show less
📄 PDF DOI: 10.1158/0008-5472.CAN-19-1027
MAP2K5
Jiwon Park, Yunkyoung Lee, Eun-Hye Jung +3 more · 2020 · Biochimica et biophysica acta. Molecular and cell biology of lipids · Elsevier · added 2026-04-24
Dose-dependent lipid accumulation was induced by glucose in HepG2 cells. GlcN also exerted a promotory effect on lipid accumulation in HepG2 cells under normal glucose conditions (NG, 5 mM) and liver Show more
Dose-dependent lipid accumulation was induced by glucose in HepG2 cells. GlcN also exerted a promotory effect on lipid accumulation in HepG2 cells under normal glucose conditions (NG, 5 mM) and liver of normal fed zebrafish larvae. High glucose (HG, 25 mM)-induced lipid accumulation was suppressed by l-glutamine-d-fructose 6-phosphate amidotransferase inhibitors. ER stress inhibitors did not suppress HG or GlcN-mediated lipid accumulation. HG and GlcN stimulated protein expression, DNA binding and O-GlcNAcylation of carbohydrate-responsive element-binding protein (ChREBP). Furthermore, both HG and GlcN increased nuclear sterol regulatory element-binding protein-1 (SREBP-1) levels in HepG2 cells. In contrast to its stimulatory effect under NG, GlcN suppressed lipid accumulation in HepG2 cells under HG conditions. Similarly, GlcN suppressed lipid accumulation in livers of overfed zebrafish. In addition, GlcN activity on DNA binding and O-GlcNAcylation of ChREBP was stimulatory under NG and inhibitory under HG conditions. Moreover, GlcN enhanced ChREBP, SREBP-1c, ACC, FAS, L-PK and SCD-1 mRNA expression under NG but inhibited HG-induced upregulation in HepG2 cells. The O-GlcNAc transferase inhibitor, alloxan, reduced lipid accumulation by HG or GlcN while the O-GlcNAcase inhibitor, PUGNAc, enhanced lipid accumulation in HepG2 cells and liver of zebrafish larvae. GlcN-induced lipid accumulation was inhibited by the AMPK activator, AICAR. Phosphorylation of AMPK (p-AMPK) was suppressed by GlcN under NG while increased by GlcN under HG. PUGNAc downregulated p-AMPK while alloxan restored GlcN- or HG-induced p-AMPK inhibition. Our results collectively suggest that GlcN regulates lipogenesis by sensing the glucose or energy states of normal and excess fuel through AMPK modulation. Show less
no PDF DOI: 10.1016/j.bbalip.2020.158764
MLXIPL
Kyeong-Min Kim, Eun-Jung Kim, Won-Gu Jang · 2020 · The international journal of biochemistry & cell biology · Elsevier · added 2026-04-24
Carbohydrate responsive element binding protein (ChREBP) is a major transcription factor of lipogenesis regulated by glucose status in the liver. However, the function of ChREBP in osteogenic differen Show more
Carbohydrate responsive element binding protein (ChREBP) is a major transcription factor of lipogenesis regulated by glucose status in the liver. However, the function of ChREBP in osteogenic differentiation is unclear. The present study examined the role of ChREBP in osteoblast differentiation in MC3T3-E1 preosteoblast cell line. The mRNA expression of ChREBP, protein phosphatase 2A catalytic subunit-α (PP2A Cα) and the osteogenic genes such as, DNA-binding protein inhibitor (Id1), runt-related transcription factor-2 (Runx2), and alkaline phosphatase (ALP) was measured by qPCR and RT-PCR. Runx2, ChREBP, and PP2A Cα, protein levels were evaluated by Western blotting. ALP staining experiment was carried out to evaluate ALP enzyme activity, and a luciferase reporter assay was performed to analyze Runx2 transcriptional activity. Expression of ChREBP and PP2A Cα did not change during bone morphogenetic protein-2 (BMP2)-induced osteoblast differentiation. Overexpression of ChREBP reduced the osteogenic genes (Runx2 and ALP) expression and ALP activity, while knockdown of ChREBP had the opposite effects. Overexpression of PP2A Cα increased ChREBP expression, while inhibition of PP2A Cα using okadaic acid not only inhibited the expression of ChREBP, but also restored the mRNA and protein expression of Runx2 and activity of ALP enzyme. These results demonstrate that ChREBP inhibits BMP2-induced osteoblast differentiation in a PP2A Cα- dependent manner. Show less
no PDF DOI: 10.1016/j.biocel.2020.105766
MLXIPL
Hyung Yoon Kim, Jong Eun Park, Sang-Chol Lee +7 more · 2020 · Journal of clinical medicine · MDPI · added 2026-04-24
The spectrum of genetic variants and their clinical significance of Hypertrophic cardiomyopathy (HCM) have been poorly studied in Asian patients. The objectives of this study were to assess the spectr Show more
The spectrum of genetic variants and their clinical significance of Hypertrophic cardiomyopathy (HCM) have been poorly studied in Asian patients. The objectives of this study were to assess the spectrum of genetic variants and genotype-phenotype relationships within a Korean HCM population. Eighty-nine consecutive unrelated HCM patients were included. All patients underwent genotypic analysis for 23 HCM-associated genes. Clinical parameters including echocardiographic and cardiac magnetic resonance (CMR) parameters were evaluated. A composite of major adverse cardiac and cerebrovascular events was assessed. Genetic variants were detected in 55 of 89 subjects. Pathogenic variants or likely pathogenic variants were identified in 27 of HCM patients in Genetic variants in patients with HCM are relatively common and are associated with adverse clinical events and myocardial fibrosis on CMR. Genotypic analysis may add important information to clinical variables in the assessment of long-term risk for HCM patients. Show less
no PDF DOI: 10.3390/jcm9061671
MYBPC3
Hyemoon Chung, Yoonjung Kim, Sun-Mi Cho +14 more · 2020 · Mitochondrion · Elsevier · added 2026-04-24
Hypertrophic cardiomyopathy (HCM) is a multigenic disease that occurs due to various genetic modifiers. We investigated phenotype-based clinical and genetic characteristics of HCM patients using compr Show more
Hypertrophic cardiomyopathy (HCM) is a multigenic disease that occurs due to various genetic modifiers. We investigated phenotype-based clinical and genetic characteristics of HCM patients using comprehensive genetic tests and rare variant association analysis. A comprehensive HCM-specific panel, consisting of 82 nuclear DNAs (nDNAs: 33 sarcomere-associated genes, 5 phenocopy genes, and 44 nuclear genes linked to mitochondrial cardiomyopathy) and 37 mitochondrial DNAs (mtDNAs), was analyzed. Rare variant analysis was performed to determine the association of specific genes with different phenotypes. Among the 212 patients, pathogenic variants in sarcomere-associated genes were more prevalent in non-apical HCM (41.4%, 46/111; P = 0.001) than apical HCM (20.8%, 21/101). Apical HCM exhibits mild phenotypes than non-apical HCM, and it showed fewer numbers of sarcomere mutations than non-apical HCM. Interestingly, inverted mutation frequency of TNNI3 (35%) and MYH7 (9%) was observed in apical HCM. In a rare variant analysis, MT-RNR2 positively correlated with apical HCM (OR: 1.37, P = 0.025). And, MYBPC3 (sarcomere gene) negatively contributed to apical HCM (OR: 0.54, P = 0.027). On the other hand, both pathogenic mutation (P < 0.05) and rare variants in sarcomere-associated genes (OR: 2.78-3.47, P < 0.05) were related to diastolic dysfunction and left atrium remodeling, which correlated with poor prognosis in HCM patients. Our results provide a clue towards explaining the difference between the prevalence and phenotype of apical HCM in Asian populations, and a foundation for genetics-based approaches that may enable individualized risk stratification for HCM patients. Show less
no PDF DOI: 10.1016/j.mito.2020.04.010
MYBPC3
You-Jin Kim, Se-Hyun Oh, Ji-Sun Ahn +5 more · 2020 · International journal of molecular sciences · MDPI · added 2026-04-24
In the present study, we investigated the effects of xanthine oxidase (XO) inhibition on cholesterol-induced renal dysfunction in chronic kidney disease (CKD) mice, and in low-density lipoprotein (LDL Show more
In the present study, we investigated the effects of xanthine oxidase (XO) inhibition on cholesterol-induced renal dysfunction in chronic kidney disease (CKD) mice, and in low-density lipoprotein (LDL)-treated human kidney proximal tubule epithelial (HK-2) cells. ApoE knockout (KO) mice underwent uninephrectomy to induce CKD, and were fed a normal diet or high-cholesterol (HC) diet along with the XO inhibitor topiroxostat (1 mg/kg/day). HK-2 cells were treated with LDL (200 µg/mL) and topiroxostat (5 µM) or small interfering RNA against xanthine dehydrogenase (siXDH; 20 nM). In uninephrectomized ApoE KO mice, the HC diet increased cholesterol accumulation, oxidative stress, XO activity, and kidney damage, while topiroxostat attenuated the hypercholesterolemia-associated renal dysfunction. The HC diet induced cholesterol accumulation by regulating the expressions of genes involved in cholesterol efflux ( Show less
no PDF DOI: 10.3390/ijms21207444
NR1H3
Sunggun Kim, Yeo Yeong Yoon, Ye Won Park +3 more · 2020 · Journal of natural medicines · Springer · added 2026-04-24
Cynandione A (CA), isolated from ethyl acetate extract of Cynanchum wilfordii (CW), is a bioactive phytochemical that has been found to be beneficial for the treatment of several diseases. Hepatic de Show more
Cynandione A (CA), isolated from ethyl acetate extract of Cynanchum wilfordii (CW), is a bioactive phytochemical that has been found to be beneficial for the treatment of several diseases. Hepatic de novo lipogenesis is one of the main causes of non-alcoholic fatty liver disease (NAFLD), which is thought to be a hepatic manifestation of certain metabolic syndromes. However, it has not yet been reported if CA has any therapeutic value in these diseases. Here, we investigated whether CA can inhibit hepatic lipogenesis induced by liver X receptor α (LXRα) using an in vitro model. We found that the extract and ethyl acetated layer of CW decreased the mRNA levels of sterol regulatory element-binding protein-1c (SREBP-1c), which plays a crucial role in hepatic lipogenesis. Additionally, we observed that CA could suppress the level of SREBP-1c, which was increased using two commercial LXRα agonists, GW3954 and T0901317. Moreover, the enzymes that act downstream of SREBP-1c were also inhibited by CA treatment. To understand the mechanism underlying this effect, the levels of phosphorylated AMP kinase (pAMPK) were measured after CA treatment. Therefore, CA might increase the pAMPK level by inducing phosphorylation of liver kinase B1 (LKB1), which can then convert AMPK to pAMPK. Taken together, we conclude that CA has an alleviative effect on hepatic lipogenesis through the stimulation of the LKB1/AMPK pathway. Show less
no PDF DOI: 10.1007/s11418-019-01356-x
NR1H3
Eun-Kyung Kim, Min-Jeong Song, Ho Hee Jang +1 more · 2020 · International journal of molecular sciences · MDPI · added 2026-04-24
Thyroid cancer incidence has increased worldwide; however, investigations of thyroid cancer-related factors as potential prognosis markers remain insufficient. Secreted proteins from the cancer secret Show more
Thyroid cancer incidence has increased worldwide; however, investigations of thyroid cancer-related factors as potential prognosis markers remain insufficient. Secreted proteins from the cancer secretome are regulators of several molecular mechanisms and are, thereby, ideal candidates for potential markers. We aimed to identify a specific factor for thyroid cancer by analyzing the secretome from normal thyroid cells, papillary thyroid cancer (PTC) cells, and anaplastic thyroid cancer cells using mass spectrometry (MS). Cathepsin B (CTSB) showed highest expression in PTC cells compared to other cell lines, and CTSB levels in tumor samples were higher than that seen in normal tissue. Further, among thyroid cancer patients, increased CTSB expression was related to higher risk of lymph node metastasis (LNM) and advanced N stage. Overexpression of CTSB in thyroid cancer cell lines activated cell migration by increasing the expression of vimentin and Snail, while its siRNA-mediated silencing inhibited cell migration by decreasing vimentin and Snail expression. Mechanistically, CTSB-associated enhanced cell migration and upregulation of vimentin and Snail occurred via increased phosphorylation of p38. As our results suggest that elevated CTSB in thyroid cancer induces the expression of metastatic proteins and thereby leads to LNM, CTSB may be a good and clinically relevant prognostic marker. Show less
no PDF DOI: 10.3390/ijms21249537
SNAI1
Dae-Geun Song, Eunmi Kim, Jung Weon Lee · 2020 · Archives of pharmacal research · Springer · added 2026-04-24
Cancer metastasis involves diverse cellular functions via bidirectional communications between intracellular and extracellular spaces. To achieve development of the anti-metastatic drugs, one needs to Show more
Cancer metastasis involves diverse cellular functions via bidirectional communications between intracellular and extracellular spaces. To achieve development of the anti-metastatic drugs, one needs to consider the efficacy and mode of action (MOA) of the drug candidates to block the metastatic potentials of cancerous cells. Rather than under two-dimensional environment, investigation of the metastatic potentials under three-dimensional environment would be much pharmaceutically beneficent, since it can mimic the in vivo tumor lesions in cancer patients, leading to allowance of drug candidates analyzed in the 3D culture systems to lower failure rates during the anti-metastatic drug development. Here we have reviewed on the analyses of metastatic potentials of certain cancer models in 3D culture systems surrounded with extracellular matrix proteins, which could be supported by TM4SF5- and/or EMT-mediated actions. We particularly focused the initial events of the cancer metastasis, such as invasive outgrowth and dissemination from the cancer cell masses, spheroids, embedded in the 3D gel culture systems. This review summarizes the significance of tetraspanin TM4SF5 and Snail1 that are related to EMT in the metastatic potentials explored in the 3D gel systems. Show less
no PDF DOI: 10.1007/s12272-020-01291-6
SNAI1
Eunae Sandra Cho, Nam Hee Kim, Jun Seop Yun +3 more · 2020 · Cells · MDPI · added 2026-04-24
Efficient catabolic metabolism of adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) is essentially required for cancer cell survival, especially in metastati Show more
Efficient catabolic metabolism of adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) is essentially required for cancer cell survival, especially in metastatic cancer progression. Epithelial-mesenchymal transition (EMT) plays an important role in metabolic rewiring of cancer cells as well as in phenotypic conversion and therapeutic resistance. Snail (SNAI1), a well-known inducer of cancer EMT, is critical in providing ATP and NADPH via suppression of several gatekeeper genes involving catabolic metabolism, such as phosphofructokinase 1 (PFK1), fructose-1,6-bisphosphatase 1 (FBP1), and acetyl-CoA carboxylase 2 (ACC2). Paradoxically, PFK1 and FBP1 are counter-opposing and rate-limiting reaction enzymes of glycolysis and gluconeogenesis, respectively. In this study, we report a distinct metabolic circuit of catabolic metabolism in breast cancer subtypes. Interestingly, PFKP and FBP1 are inversely correlated in clinical samples, indicating different metabolic subsets of breast cancer. The luminal types of breast cancer consist of the pentose phosphate pathway (PPP) subset by suppression of PFKP while the basal-like subtype (also known as triple negative breast cancer, TNBC) mainly utilizes glycolysis and mitochondrial fatty acid oxidation (FAO) by loss of FBP1 and ACC2. Notably, PPP remains active via upregulation of TIGAR in the FBP1-loss basal-like subset, indicating the importance of PPP in catabolic cancer metabolism. These results indicate different catabolic metabolic circuits and thus therapeutic strategies in breast cancer subsets. Show less
no PDF DOI: 10.3390/cells9092064
SNAI1
Jung Hwa Moon, Sang Hyuk Lee, Bon Seok Koo +6 more · 2020 · Oral oncology · Elsevier · added 2026-04-24
The acquisition of stem-like phenotype is partly attributed to the induction of epithelial-mesenchymal transition (EMT). Thus, the activation of factors involved in EMT can be linked to cancer stem ce Show more
The acquisition of stem-like phenotype is partly attributed to the induction of epithelial-mesenchymal transition (EMT). Thus, the activation of factors involved in EMT can be linked to cancer stem cell genesis. However, the underlying mechanisms in head and neck squamous cell carcinoma (HNSCC) remain largely unknown. Herein, we investigate whether slug, one of the major effectors of EMT, affects the stemness of HNSCC cells. We performed in vitro experiments to determine whether slug gene manipulation can influence the stemness phenotypes, including the capacity for self-renewal, expression of putative stemness markers, chemoresistance, and invasion in HNSCC cells. Further, we identified whether Slug knockout attenuates tumorigenicity of HNSCC cells in vivo. Finally, we examined whether prognosis of HNSCC patients after curative treatment may be affected by the level of slug expression. Overexpression of slug promoted self-renewal of HNSCC cells via activation of sphere formation, the expression of stem cell markers, and induction of chemoresistance to cisplatin. Also, slug overexpression increased the migration and invasion of HNSCC cells in vitro and was mainly observed during the invasion in HNSCC xenograft mouse model. By contrast, slug expression knockdown abrogated their self-renewal capacity, stemness-associated gene expression, and cisplatin chemoresistance. Furthermore, high levels of slug expression correlated with poor prognosis of patients with HNSCC. Inhibition of slug expression may represent a novel therapeutic strategy targeting HNSCC stem-like cells. Show less
no PDF DOI: 10.1016/j.oraloncology.2020.104948
SNAI1
Hyeonseok Ko, Gyuwon Huh, Sang Hoon Jung +4 more · 2020 · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · Elsevier · added 2026-04-24
Persimmon (Diospyros kaki L.f.) trees are widely cultivated for their edible fruits in Asia. D. kaki leaves are abundant in phytochemicals that have numerous medicinal properties. Hepatocyte growth fa Show more
Persimmon (Diospyros kaki L.f.) trees are widely cultivated for their edible fruits in Asia. D. kaki leaves are abundant in phytochemicals that have numerous medicinal properties. Hepatocyte growth factor (HGF) and its receptor Met lead to poor prognosis via the promotion of metastasis and chemoresistance in hepatocellular carcinoma (HCC). Therefore, inhibitors targeting the HGF/Met pathway are regarded as promising drugs against HCC. Here, we investigated the effects of D. kaki leaves on HGF-induced epithelial-to-mesenchymal transition (EMT) and stemness traits in HCC. The ethanol extract of D. kaki leaves (EEDK) markedly suppressed HGF-mediated cell migration and invasion through upregulation of CDH1 and downregulation of SNAI1, VIM, MMP1, MMP2, and MMP9. Moreover, EEDK increased the cytotoxicity of sorafenib, which was reduced by HGF, and decreased the expression of the stemness markers KRT19 and CD44. Additionally, we found a clear correlation between stemness and EMT markers in HCC patients. Importantly, EEDK reduced Met activity and attenuated HGF-mediated activation of JNK/c-Jun. Our findings provide new evidence that EEDK can ameliorate HCC with poor prognosis and aggressive phenotype by blocking HGF/Met signaling. Show less
no PDF DOI: 10.1016/j.fct.2020.111475
SNAI1
Ji Hye Yang, Nam Hee Kim, Jun Seop Yun +11 more · 2020 · Life science alliance · added 2026-04-24
Despite the importance of mitochondrial fatty acid oxidation (FAO) in cancer metabolism, the biological mechanisms responsible for the FAO in cancer and therapeutic intervention based on catabolic met Show more
Despite the importance of mitochondrial fatty acid oxidation (FAO) in cancer metabolism, the biological mechanisms responsible for the FAO in cancer and therapeutic intervention based on catabolic metabolism are not well defined. In this study, we observe that Snail (SNAI1), a key transcriptional repressor of epithelial-mesenchymal transition, enhances catabolic FAO, allowing pro-survival of breast cancer cells in a starved environment. Mechanistically, Snail suppresses mitochondrial ACC2 (ACACB) by binding to a series of E-boxes located in its proximal promoter, resulting in decreased malonyl-CoA level. Malonyl-CoA being a well-known endogenous inhibitor of fatty acid transporter carnitine palmitoyltransferase 1 (CPT1), the suppression of ACC2 by Snail activates CPT1-dependent FAO, generating ATP and decreasing NADPH consumption. Importantly, combinatorial pharmacologic inhibition of pentose phosphate pathway and FAO with clinically available drugs efficiently reverts Snail-mediated metabolic reprogramming and suppresses in vivo metastatic progression of breast cancer cells. Our observations provide not only a mechanistic link between epithelial-mesenchymal transition and catabolic rewiring but also a novel catabolism-based therapeutic approach for inhibition of cancer progression. Show less
no PDF DOI: 10.26508/lsa.202000683
SNAI1
Junyeob Kwon, David M Helfman, Mi-Young Kim · 2020 · Biochemical and biophysical research communications · Elsevier · added 2026-04-24
The adaptive activation of alternative signaling pathways contributes to acquired resistance against targeted cancer therapies. Our previous research has shown that blocking Ras/ERK signaling promotes Show more
The adaptive activation of alternative signaling pathways contributes to acquired resistance against targeted cancer therapies. Our previous research has shown that blocking Ras/ERK signaling promotes PI3K/AKT signaling in the lung metastatic derivative of MDA-MB-231 (LM2). Because AKT activation was required to drive sustained cell motility following MEK suppression, we extend our research to elucidate how activation of the PI3K/AKT signaling drives sustained motility following MEK inhibition. Reverse phase protein array (RPPA) revealed that SNAIL (SNAI1) was upregulated in U0126 (MEK inhibitor)-treated LM2 cells. Importantly, LM2 cells simultaneously treated with U0126 and PI3K inhibitor LY294002 exhibited reduced expression of SNAIL. Furthermore, depletion of SNAIL led to reduced cell motility in U0126-treated LM2 cells. In addition, we identified AXL as another downstream effector of AKT. These results suggest that SNAIL and AXL are key factors mediating sustained motility of LM2 cells following MEK suppression. Because AKT mediates motile behavior under MEK suppression, our results suggest that AKT and AXL may be targeted to overcome resistance against drugs targeting the Ras/ERK pathway. Show less
no PDF DOI: 10.1016/j.bbrc.2020.05.043
SNAI1
Sung Yong Choi, Dong Woo Lee, Bokhyun Song +5 more · 2020 · Oral oncology · Elsevier · added 2026-04-24
The widely used in vitro invasion assays for head and neck squamous cell carcinoma (HNSCC) are wound healing, transwell, and organotypic assays. However, these are still lab-intensive and time-consumi Show more
The widely used in vitro invasion assays for head and neck squamous cell carcinoma (HNSCC) are wound healing, transwell, and organotypic assays. However, these are still lab-intensive and time-consuming tasks. For the rapid detection and high throughput screening of invasiveness in 3D condition, we propose a novel spheroid invasion assay using commercially available pillar platform system. Using the pillar-based spheroid invasion assay, migration and invasion was evaluated in three patient-derived cells (PDCs) of HNSCC. Immunofluorescence of live cells was used for the quantitative measurement of migratory and invaded cells attached to the pillar. Expression of epithelial-mesenchymal transition (EMT)-related gene (snai1/2) was measured by qRT-PCR. We also tested the impact of drug treatments (cisplatin, docetaxel) on the changes in the invasive phenotype. All PDCs successfully formed spheroid at 4 days and can be measured invasiveness within 7 days. Intriguingly, one PDC (#1) obtained from the advanced stage showed robust migration, invasion and higher transcription of snai1/2, compared with the other two PDCs. Furthermore, the invasion ratio of the control spheroids was about 70% while the invasion ratios of drug-treated spheroids were lower than 50%, and the difference showed statistical significance (p < 0.01). The presented spheroid invasion assay using pillar array could be useful for the evaluation of cancer cell behavior and physiology in response to diverse therapeutic drugs. Show less
no PDF DOI: 10.1016/j.oraloncology.2020.104807
SNAI1
Gye Lim Kim, Eun Hyang Jang, Da-Eun Lee +8 more · 2020 · Archives of biochemistry and biophysics · Elsevier · added 2026-04-24
Epithelial mesenchymal transition (EMT) is a well-known and important step in metastasis and thus can be a key target in cancer treatment. Here, we tested the EMT inhibitory actions of Selaginella tam Show more
Epithelial mesenchymal transition (EMT) is a well-known and important step in metastasis and thus can be a key target in cancer treatment. Here, we tested the EMT inhibitory actions of Selaginella tamariscina and its active component, amentoflavone (AF). EMT was examined in vitro using wound-healing and invasion assays and by monitoring changes in the expression of the EMT-related proteins, E-cadherin, Snail, and Twist. Metastasis was examined in vivo using SCID mice injected with luciferase-labeled A549 cells. We confirmed that aqueous extracts of S. tamariscina (STE) and AF inhibited EMT in human cancer cell lines. We found that STE and AF at nontoxic concentrations exerted remarkable inhibitory effects on migration (wound healing assay) and invasion (Transwell assay) in tumor necrosis factor (TGF)-β-treated cancer cells. Western blotting and immunofluorescence imaging show that AF treatment also restored E-cadherin expression in these cells compared to cells treated with TGF-β only. Suppression of metastasis by AF was investigated by monitoring migration of tail-vein-injected, circulating A549-luc cells to the lungs in mice. After 3 wk, fewer nodules were observed in mice co-treated with AF compared with those treated with TGF-β only. Our findings indicate that STE and AF are promising EMT inhibitors and, ultimately, potentially potent antitumor agents. Show less
no PDF DOI: 10.1016/j.abb.2020.108384
SNAI1
Josh Lewis Stern, Grace Hibshman, Kevin Hu +6 more · 2020 · Molecular cancer research : MCR · added 2026-04-24
In a substantial fraction of cancers
no PDF DOI: 10.1158/1541-7786.MCR-19-1244
SNAI1
Yoo Min Park, Eunji Ha, Ki-Nam Gu +4 more · 2020 · Clinical and translational gastroenterology · added 2026-04-24
The family history of inflammatory bowel disease (IBD) has been strongly associated with risk of developing IBD. This study aimed to identify the host genetic and gut microbial signatures in familial Show more
The family history of inflammatory bowel disease (IBD) has been strongly associated with risk of developing IBD. This study aimed to identify the host genetic and gut microbial signatures in familial IBD. Genetic analyses using genome-wide single nucleotide polymorphism genotyping and whole exome sequencing were performed to calculate weighted genetic risk scores from known IBD-associated common variants and to identify rare deleterious protein-altering variants specific to patients with familial IBD in 8 Korean families that each included more than 2 affected first-degree relatives (FDRs) and their unaffected FDR(s). In parallel, gut microbial community was analyzed by 16S rRNA sequencing of stools from the sample individuals. The risk of familial IBD was not well explained by the genetic burden from common IBD-risk variants, suggesting the presence of family-shared genetic and environmental disease-risk factors. We identified 17 genes (AC113554.1, ACE, AKAP17A, AKAP9, ANK2, ASB16, ASIC3, DNPH1, DUS3L, FAM200A, FZD10, LAMA5, NUTM2F, PKN1, PRR26, WDR66, and ZC3H4) that each contained rare, potentially deleterious variants transmitted to the affected FDRs in multiple families. In addition, metagenomic analyses revealed significantly different diversity of gut microbiota and identified a number of differentially abundant taxa in affected FDRs, highlighting 22 novel familial disease-associated taxa with large abundance changes and the previously reported gut dysbiosis including low alpha diversity in IBD and 16 known IBD-specific taxa. This study identified familial IBD-associated rare deleterious variants and gut microbial dysbiosis in familial IBD. Show less
no PDF DOI: 10.14309/ctg.0000000000000213
ZC3H4
Eun Jin Kwon, Hye Ah Lee, Young-Ah You +5 more · 2019 · Medicine · added 2026-04-24
Although the changes in DNA methylation are assumed to be due to the association between adverse intrauterine conditions and adult metabolic health, evidence from human studies is rare. Little is know Show more
Although the changes in DNA methylation are assumed to be due to the association between adverse intrauterine conditions and adult metabolic health, evidence from human studies is rare. Little is known about the changes in DNA methylation present at birth that affect metabolic profiles in childhood. Previous studies have shown that the melanocortin 4 receptor (MC4R) and hepatocyte nuclear factor 4 alpha (HNF4α) genes are associated with obesity and metabolic disorders. Thus, we investigated the associations of the DNA methylation statuses of MC4R and HNF4α in cord blood with metabolic profiles in childhood.We collected data from 90 children 7 to 9 years of age included in the Ewha Birth & Growth Cohort Study in Korea. DNA methylation was analyzed by pyrosequencing. The children were split into 2 groups according to the cutoff triglyceride (TG) levels (<110 and ≥110 mg/dL).The methylation statuses of MC4R and HNF4α at birth were significantly associated with the TG level in childhood (P < .05). It was interesting to note that the methylation statuses of MC4R and HNF4α in cord blood were significantly decreased, whereas childhood body mass index was significantly increased, in children with high TG levels compared with children with low TG levels (P < .05).Our findings show that the methylation statuses of MC4R and HNF4α at birth are associated with metabolic profiles in childhood. These epigenetic modifications occurring in early life may contribute to subsequent metabolic-related disorders. Thus, we suggest that DNA methylation status in cord blood may be predictive of the risk of developing metabolic syndrome. Show less
📄 PDF DOI: 10.1097/MD.0000000000016424
MC4R
Boo-Young Kim, Ju Yeon Park, Eui Jin Kim +3 more · 2019 · International forum of allergy & rhinology · Wiley · added 2026-04-24
Several studies have reported the benefits of olfactory training (OT) in the olfactory nervous system of mouse models. Therefore, in this study we performed next-generation sequencing to evaluate the Show more
Several studies have reported the benefits of olfactory training (OT) in the olfactory nervous system of mouse models. Therefore, in this study we performed next-generation sequencing to evaluate the effects of OT on mRNA sequencing in the olfactory area. Mice in each group were administered 300 mg of 3-methylindole per kilogram of mouse weight. The olfactory function was evaluated by a food-finding test once a week. The olfactory neuroepithelium was harvested for histologic examination and protein analysis. Subsequently, data analysis, gene ontology and pathway analysis, quantitative real-time polymerase chain reaction of mRNA, and Western blot analysis were conducted. Mice were divided into 4 groups according to treatment. Control, anosmia, training, and steroid group mice resumed food finding. Olfactory Maker Protein, olfr1507, ADCY3, and GNAL mRNA expression was higher in the olfactory neuroepithelium of OT than anosmia group mice. In total, 26,364 mRNAs were analyzed. Comparison of the results of OT vs anosmia revealed that ADCY8,10, GFAP, NGF, NGFR, GFAP, and BDNF mRNAs were upregulated in the gene ontology. OT improved olfactory function, as indicated by the food-finding test. OT improved the olfactory recovery time to stimulate olfactory nerve regeneration. OT may initially stimulate the olfactory receptor, followed by neurogenesis. Steroid therapy and OT operated under completely different mechanisms in the upregulated gene study. These results indicate that OT may be one of the future modalities for treating olfactory impairment. Show less
📄 PDF DOI: 10.1002/alr.22320
ADCY3
Dong Im Cho, Hye-Jin Kang, Ju Hee Jeon +9 more · 2019 · JCI insight · added 2026-04-24
Mesenchymal stem cells (MSCs) can suppress pathological inflammation. However, the mechanisms underlying the association between MSCs and inflammation remain unclear. Under coculture conditions with m Show more
Mesenchymal stem cells (MSCs) can suppress pathological inflammation. However, the mechanisms underlying the association between MSCs and inflammation remain unclear. Under coculture conditions with macrophages, MSCs highly expressed angiopoietin-like 4 (ANGPTL4) to blunt the polarization of macrophages toward the proinflammatory phenotype. ANGPTL4-deficient MSCs failed to inhibit the inflammatory macrophage phenotype. In inflammation-related animal models, the injection of coculture medium or ANGPTL4 protein increased the antiinflammatory macrophages in both peritonitis and myocardial infarction. In particular, cardiac function and pathology were markedly improved by ANGPTL4 treatment. We found that retinoic acid-related orphan receptor α (RORα) was increased by inflammatory mediators, such as IL-1β, and bound to ANGPTL4 promoter in MSCs. Collectively, RORα-mediated ANGPTL4 induction was shown to contribute to the antiinflammatory activity of MSCs against macrophages under pathological conditions. This study suggests that the capability of ANGPTL4 to induce tissue repair is a promising opportunity for safe stem cell-free regeneration therapy from a translational perspective. Show less
no PDF DOI: 10.1172/jci.insight.125437
ANGPTL4
Sun Woong Kim, Donald J Brown, James V Jester · 2019 · The ocular surface · Elsevier · added 2026-04-24
PPARγ plays a critical role in the maturation of immortalized human meibomian gland epithelial cells (hMGEC). To further understand the molecular changes associated with meibocyte differentiation, we Show more
PPARγ plays a critical role in the maturation of immortalized human meibomian gland epithelial cells (hMGEC). To further understand the molecular changes associated with meibocyte differentiation, we analyzed transcriptome profiles from hMGEC after PPARγ activation. Three sets of cultivated hMGEC with or without exposure to PPARγ agonist, rosiglitazone were used for RNA-seq analysis. RNA was isolated and processed to generate 6 libraries. The libraries were then sequenced and mapped to the human reference genome, and the expression results were gathered as reads per length of transcript in kilobases per million mapped reads (RPKM) values. Differential gene expression analyses were performed using DESeq2 and NOISeq. Gene ontology enrichment analysis (GOEA) was performed on gene sets that were upregulated or downregulated after rosiglitazone treatment. Five genes were selected for validation and differential expression was confirmed using quantitative PCR. The Differential expression of CK5 was evaluated using Western blotting. Expression data indicated that about 58,000 genes are expressed in hMGEC. DESeq2 and NOISeq indicated that 296 and 3436 genes were upregulated and 258 and 3592 genes were down regulated after rosiglitazone treatment, respectively. Of genes showing significant differences > 2 fold, GOEA indicated that cellular and metabolic processes were highly represented. Expression of ANGPTL4, PLIN2, SQSTM1, and DDIT3 were significantly upregulated and HHIP was downregulated by rosiglitazone. CK5 was downregulated by rosiglitazone. The RNA-seq data suggested that PPARγ activation induced alterations in cell differentiation and metabolic process and affected multiple signaling pathways such as PPAR, autophagy, WNT, and Hedgehog. Show less
📄 PDF DOI: 10.1016/j.jtos.2019.02.003
ANGPTL4
Hyejin Kim, Oliver Worsley, Edwin Yang +11 more · 2019 · Cellular and molecular life sciences : CMLS · Springer · added 2026-04-24
Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is thought to be reversible by changing the diet. To examine the impact of dietary changes on progression and cure of NAFLD, Show more
Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is thought to be reversible by changing the diet. To examine the impact of dietary changes on progression and cure of NAFLD, we fed mice a high-fat diet (HFD) or high-fructose diet (HFrD) for 9 weeks, followed by an additional 9 weeks, where mice were given normal chow diet. As predicted, the diet-induced NAFLD elicited changes in glucose tolerance, serum cholesterol, and triglyceride levels in both diet groups. Moreover, the diet-induced NAFLD phenotype was reversed, as measured by the recovery of glucose intolerance and high cholesterol levels when mice were given normal chow diet. However, surprisingly, the elevated serum triglyceride levels persisted. Metagenomic analysis revealed dietary-induced changes of microbiome composition, some of which remained altered even after reversing the diet to normal chow, as illustrated by species of the Odoribacter genus. Genome-wide DNA methylation analysis revealed a "priming effect" through changes in DNA methylation in key liver genes. For example, the lipid-regulating gene Apoa4 remained hypomethylated in both groups even after introduction to normal chow diet. Our results support that dietary change, in part, reverses the NAFLD phenotype. However, some diet-induced effects remain, such as changes in microbiome composition, elevated serum triglyceride levels, and hypomethylation of key liver genes. While the results are correlative in nature, it is tempting to speculate that the dietary-induced changes in microbiome composition may in part contribute to the persistent epigenetic modifications in the liver. Show less
no PDF DOI: 10.1007/s00018-019-03114-4
APOA4
Han-Kyul Kim, Muhammad Ayaz Anwar, Sangdun Choi · 2019 · Scientific reports · Nature · added 2026-04-24
In this association study on chromosome 11, the data from 12,537 Korean individuals within the Health Examinee (HEXA) and the Korea Association Resource (KARE) projects were analysed to identify genet Show more
In this association study on chromosome 11, the data from 12,537 Korean individuals within the Health Examinee (HEXA) and the Korea Association Resource (KARE) projects were analysed to identify genetic loci correlating with increased and decreased plasma triglyceride (TG) levels. We identified a locus in chromosomal region 11q23.3 that harbours genes BUD13, ZNF259, APOA5, APOA1, and SIK3, which may be associated with plasma TG levels. In this locus, 13 relevant single-nucleotide polymorphisms (SNPs) were found: rs184616707, rs118175510, rs60954647, rs79408961, and rs180373 (near BUD13); rs11604424 (in ZNF259); rs2075291, rs651821, and rs7123666 (in or near APOA5); rs525028 (near APOA1), and rs645258, rs10160754, and rs142395187 (in or near SIK3). All 13 SNPs satisfied the genome-wide significance level (P < 5.0 × 10 Show less
📄 PDF DOI: 10.1038/s41598-019-44699-x
APOA5
Minjoo Kim, Hye Jin Yoo, Hwa Jin Lee +1 more · 2019 · Hypertension research : official journal of the Japanese Society of Hypertension · Nature · added 2026-04-24
We aimed to evaluate whether the longitudinal interaction between APOA5-1131C variants and overweight could accelerate age-related increases in arterial stiffness and circulating triglycerides in heal Show more
We aimed to evaluate whether the longitudinal interaction between APOA5-1131C variants and overweight could accelerate age-related increases in arterial stiffness and circulating triglycerides in healthy subjects. This 3-year prospective cohort study included 503 healthy subjects. Brachial-ankle pulse wave velocity (baPWV), triglycerides, APOA5 -1131T > C, apolipoprotein (apo) A-V level, and low-density lipoprotein (LDL) particle size were measured at baseline and within a mean follow-up period of 3 years. At the 3-year follow-up, in the overweight group, subjects with the C allele showed increases in triglycerides and baPWV relative to baseline. Additionally, in the overweight group, there was a genotype effect on changes in triglycerides: subjects with the C allele had greater increases in triglyceride concentrations than subjects with the TT genotype. Furthermore, overweight subjects with the C allele had greater increases in triglyceride concentrations than normal-weight subjects with the C allele (P-interaction = 0.013). Overweight subjects with the C allele had greater increases in baPWV than normal-weight subjects with the C allele (P-interaction = 0.047). Changes in baPWV were affected by age, baseline baPWV, and changes in systolic blood pressure (BP) and triglycerides. Changes in triglycerides were affected by APOA5 -1131T > C genotype, age, baseline triglyceride level, and changes in BMI and apo A-V. In the overweight group, changes in baPWV were affected by changes in systolic BP, LDL particle size, and triglycerides. This prospective study shows that the interactive effect between APOA5 -1131C variants and overweight can accelerate age-related increase in arterial stiffness via the regulation of circulating triglycerides in healthy subjects. Show less
no PDF DOI: 10.1038/s41440-018-0137-y
APOA5
Jae Woong Sull, Soriul Kim, Sun Ha Jee · 2019 · Journal of lipid and atherosclerosis · added 2026-04-24
The aim of this study was to examine the associations of cholesterol ester transfer protein ( We analyzed the association of We found that the These findings indicate that
📄 PDF DOI: 10.12997/jla.2019.8.2.252
CETP
Kyung-Hyun Cho, Myung-Ae Bae, Jae-Ryong Kim · 2019 · Cardiovascular therapeutics · added 2026-04-24
Cuban sugarcane wax acids (SCWA) and policosanol (PCO) are mixtures of higher aliphatic acids and alcohols, respectively, purified from sugarcane wax with different chief components. Although it has b Show more
Cuban sugarcane wax acids (SCWA) and policosanol (PCO) are mixtures of higher aliphatic acids and alcohols, respectively, purified from sugarcane wax with different chief components. Although it has been known that they have antioxidant and anti-inflammatory activities, physiological properties on molecular mechanism of SCWA have been less studied than PCO. In this study, we compared antiatherogenic activities of SCWA and PCO via encapsulation with reconstituted high-density lipoproteins (rHDL). After reconstitution, SCWA-rHDL showed smaller particle size than PCO-rHDL with increase of content. PCO-rHDL or SCWA-rHDL showed distinct inhibition of glycation with similar extent in the presence of fructose. PCO-rHDL or SCWA-rHDL showed strong antioxidant activity against cupric ion-mediated oxidation of low-density lipoproteins (LDL), and inhibition of oxLDL uptake into macrophages. Although PCO-rHDL showed 1.2-fold stronger inhibition against cholesteryl ester transfer protein (CETP) activity than SCWA-rHDL, SCWA-rHDL enhanced 15% more brain cell (BV-2) growth and 23% more regeneration of tail fin in zebrafish. PCO and SCWA both enhance the beneficial functions of HDL to maximize its antioxidant, antiglycation, and antiatherosclerotic activities and the inhibition of CETP. These enhancements of HDL functionality by PCO and SCWA could exert antiaging and rejuvenation activity. Show less
📄 PDF DOI: 10.1155/2019/8496409
CETP